NIH-funded research R01 grant

TB infection and heart health: how latent TB may raise diabetes and heart disease risk

Official title: Tuberculosis infection and risk of diabetes mellitus and cardiovascular disease: Epigenetic and cardiometabolic trajectories after TB infection

Funded at Emory University · NIH-11389260 · Data updated 2026-11-12

This project looks at whether having latent tuberculosis infection raises the chances of developing diabetes and cardiovascular disease, and what epigenetic clues might explain this link.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startAugust 8, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$791,611
NIH project number5R01AI184529-02
Project IDNIH-11389260 on NIH RePORTER

Who could benefit from this research

Could help

Adults with latent TB infection or related cardiometabolic risk profiles who participate in long-term follow-up studies.

Less likely to help

People without LTBI or without risk factors may see limited direct benefit.

What this research studies

If you have latent TB infection, this study will follow participants to see how it relates to diabetes and heart health over time. Researchers will look for epigenetic patterns that could explain why LTBI might influence cardiometabolic risk. The goal is to improve understanding and guide future prevention recommendations for people with LTBI. The study aims to translate findings into care guidelines to prevent diabetes and cardiovascular disease in those with LTBI.

Why it matters

Potential benefit: If successful, the work could lead to better strategies to prevent diabetes and heart disease in people with LTBI.

How similar studies have gone: Previous research shows a link between TB disease and cardiometabolic risk, but LTBI’s impact is less understood and this is a novel direction.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Magee, Matthew James — Emory University
  • Study coordinator: Magee, Matthew James

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.